More Scrutiny Means Strict Regulation and OpportunityByKenneth Maxik, MBA, MBB, FACHE,Diane Karns, PhD, RPh, BCSCPApril 9th 2021Pharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.